Resolvin E1 and calvarial defects in rats: a comprehensive histological analysis

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Oral and Maxillofacial Surgery

Background:

• Bone loss is a significant clinical challenge in dentistry, associated with periodontal diseases and periimplantitis.
• Effective bone regeneration strategies are crucial for treating critical size defects.

Purpose of the Study:

• To evaluate the in vivo efficacy of local Resolvin E1 (RvE1) application on bone regeneration.
• To compare the effects of RvE1 alone, bone graft alone, and RvE1 combined with bone graft in critical size calvarial defects.

Main Methods:

• Critical size calvarial defects (5 mm) were created in Wistar rats.
• Animals were divided into four groups: no treatment, bovine bone graft, RvE1, and RvE1 with bovine bone graft.
• Histological examination assessed bone regeneration, density, integration, and inflammatory response after 12 weeks.

Main Results:

• RvE1 combined with bovine bone graft significantly enhanced bone formation compared to either treatment alone.
• Statistically significant differences were observed in most quantitative histological parameters (p ≤ 0.05).
• Increased cellularity and granulation tissue were noted but not statistically significant between groups.

Conclusions:

• Local application of Resolvin E1 (RvE1) alongside bone grafting is a promising strategy for enhancing bone regeneration.
• This combination therapy may offer a superior approach for addressing bone defects in oral and maxillofacial applications.